Companies

It’s full steam ahead for Claret Medical as it announces Series B financing that will take it a long way down the road to US FDA approval, assuming its pivotal study goes to plan.

Cook Medical has initiated a recall of 696 of its CloverSnare™ 4-Loop Vascular Retrieval Snare devices because of a potential for device failure with serious consequences.

It might seem obvious that the heightened level of care provided by remote monitoring of cardiovascular conditions would result in only good things for patients. A new study, published in The Lancet, confirms it.

Sounds like a plan. Combine the offerings of one of the Cardiovascular big boys with wire forming company’s expertise and FFR technology is likely to benefit.

Cook’s peripheral drug stent, the first of its kind in China, is being conducted at up to 20 clinical sites and will enroll 175 patients with one-year follow-up.

JenaValve isn’t yet a household name in transcatheter aortic valve circles, but its new Chief Tech officer might just see that change.

The U.S. device sales tax, reimbursement and regulatory challenges and tightened healthcare spending all favour the installed company…so why not buy it?

Volcano’s revenue guidance is well down on last quarter, although the company says it’s actions to reduce costs will mean the bottom line looks unchanged.

Medtronic’s new Performa® Quadripolar Lead and Viva® Quad CRT-Ds claims optimal and efficient Cardiac Resynchronization Therapy

Embattled spinal scaffold developer, InVivo Therapeutics looks like it’s got a hold of its finances as it proceeds down the rocky road through trials to ultimate approval.

Ethicon Endo-Surgery says its newly launched device offers surgeons improved thermal management coupled with greater precision and speed when performing resection during open procedures.

Win Win as Symmetry Divests OEM Solutions to Tecomet for $450 million

Smith & Nephew is to offer a no-frills service to joint customers in the U.S., but what this amounts to other than not having the rep in attendance, is unclear.

Boston Scientific’s Agent™ Paclitaxel-Coated PTCA Balloon Catheter has gained CE mark approval and will now be launched in Europe.

Italian cardiovascular device maker Sorin Group, has gained U.S. FDA approval for the Solo Smart™ Aortic Pericardial Heart Valve which the company claims is the first biological valve to feature a fully removable stent.

Take out the $750 million settlement from Medtronic and Edwards would still be happy with a healthy sales increase over the equivalent quarter a year ago.